Zolmitriptan Od Tablet, Orally Disintegrating
Product Images NDC 59746-461

9 FDA label images from Jubilant Cadista Pharmacuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Zolmitriptan Od (NDC 59746-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Cadista Pharmacuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolmitriptan Structure (Structure)

Zolmitriptan Structure (Structure)
Chemical structure diagram of zolmitriptan, displaying its molecular framework with fused aromatic rings and side chains consistent with the active ingredient zolmitriptan.*
FDA Label Image

2.5 mg Carton (Carton 2.5 mg)

2.5 mg Carton (Carton 2.5 mg)
Packaging label for Zolmitriptan Orally Disintegrating Tablets 2.5 mg by Jubilant Cadista Pharmaceuticals Inc. The label includes the brand logo, dosage form as orally disintegrating tablets, strength 2.5 mg, unit dose packaging (6 x 3 tablets), and storage instructions. The label also states manufacturer Jubilant Generics Ltd, Roorkee, India, and marketer Jubilant Cadista Pharmaceuticals Inc., USA.*
FDA Label Image

5 mg Blister Carton (Carton 5 mg)

5 mg Blister Carton (Carton 5 mg)
Packaging label for Zolmitriptan OD 5 mg orally disintegrating tablets by Jubilant Cadista Pharmaceuticals Inc. The label shows unit-dose packaging with a 3-count box. It includes storage instructions, manufacturer and marketer information, barcode, and NDC 59746-462-13.*
FDA Label Image

Fig 1 (Figure 1)

Fig 1 (Figure 1)
A line graph depicting the estimated probability of response over time from initial dose for placebo and zolmitriptan doses (1 mg, 2.5 mg, 5 mg). The x-axis represents time from initial dose (0 to 4 hours) and the y-axis shows estimated probability of response (0% to 100%). Four lines compare response probabilities at various times.*
FDA Label Image

Fig 2 (Figure 2)

Fig 2 (Figure 2)
A line graph showing the estimated probability of medication rescue over 24 hours from the initial dose. The x-axis represents time in hours, and the y-axis represents probability as a percentage. Four curves are displayed, labeled placebo, 1 mg, 2.5 mg, and 5 mg, illustrating their respective probabilities over time.*
FDA Label Image

Fig 3 (Figure 3)

Fig 3 (Figure 3)
A line graph depicting the estimated probability of response over time from initial dose for Zolmitriptan Orally Disintegrating Tablets 2.5 mg versus placebo. The x-axis represents time intervals (0, 0.5, 1, 1.5, 2 hours), and the y-axis shows the estimated probability of response from 0% to 100%. Zolmitriptan shows an increasing response probability over time, higher than placebo at each time point.*
FDA Label Image

Fig 4 (Figure 4)

Fig 4 (Figure 4)
A line graph comparing the estimated probability of remediation or rescue over 24 hours between placebo and Zolmitriptan Orally Disintegrating Tablets 2.5 mg. The x-axis represents time in hours from the initial dose, and the y-axis shows the probability percentage. The placebo group has a higher probability curve compared to the Zolmitriptan 2.5 mg group across the time period.*
FDA Label Image

2.5 mg Foil (Foil 2.5 mg)

2.5 mg Foil (Foil 2.5 mg)
Packaging label for Zolmitriptan OD Orally Disintegrating Tablet, 2.5 mg strength, labeled for prescription use only. The manufacturer is Jubilant Cadista Pharmaceuticals Inc. The label includes a barcode, dosage form, and storage instruction to protect from light and moisture. The label is designed with perforated edges for easy tab removal.*
FDA Label Image

5 mg Blister Foil (Foil 5 mg)

5 mg Blister Foil (Foil 5 mg)
Packaging label for Zolmitriptan Orally Disintegrating Tablet, 5 mg strength. The label shows the product name, dosage form, and strength prominently, with instructions to protect from light and moisture. It includes a barcode and is labeled as prescription only (Rx only). The labeler is Jubilant Cadista Pharmaceuticals Inc., and the product is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.